Manager, Safety Analysis Scientist at Johnson & Johnson Innovative Medicine. /Translational & Expt research. Immunology, Cell and Molecular Biology. Virology, inflammatory and infectious disease expert/ Leader.
Today, I celebrate yet another significant achievement as we unraveled the potential of interleukin-26 as both a biomarker and a target for therapeutic intervention in severe asthma. Much gratitude to the dedicated team at KI whose relentless efforts brought this breakthrough to fruition. The essence of scientific exploration transcends mere discovery; it embodies the profound dedication of passionate researchers in piecing together intricate puzzles at the microcosmic level, even amidst apparent impossibilities. These incremental advancements, forged through dedication and perseverance, have paved the way for some of the most transformative breakthroughs, that have addressed some of humanity's most pressing health challenges today. Happy reading -:) chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://lnkd.in/dnsmpaZt
Congratulations 🎊 Machi
Bra jobbat!
Congratulations!
Fantastic!! Asthma is so complex. As you mention, I would love to see a second paper measuring cytokines in sputum or lavage. We ingest environmental allergens every day which contribute to esophagitis and asthma!